N4 Pharma plc (N4P) ORD GBP0.004
0.55p
(5.53%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.55p
(5.53%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.55p
(5.53%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
9.80p
10.20p
15.50p
£17.75 million
9.95p
9.25p
4.45p
n/a
0.60p (6.42%) Previous:
0.60p
1,440,975
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2020 | 31/12/2019 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (1.57) | (0.95) |
| Adjusted EPS (p): | (0.96) | (0.87) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
N4 Pharma losses widen as it works on commercialising Nuvec
24 February 2021 12:34
-
N4 Pharma shares surge on latest from Nanomerics collaboration
3 December 2020 13:39
-
N4 Pharma working with Nanomerics on oncology programme
9 November 2020 14:22
-
Second Price Monitoring Extn
5 July 2021 16:41
-
Price Monitoring Extension
5 July 2021 16:36
-
Second Price Monitoring Extn
20 May 2021 09:05
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.